Abstract: An object of the present invention is to provide a compound useful as a therapeutic or prophylactic drug for a disease involving the immune system, by suppressing a function of immune cells by suppressing proliferation of activated T cells or suppressing production of interferon alpha (IFN-?) by activated plasmacytoid dendritic cells (pDC), particularly an autoimmune disease such as systemic lupus erythematosus (SLE) and lupus nephritis in SLE patients. The present invention provides a compound represented by general formula (I): [wherein X, R1, R2, R3, R4, R5 and R6 are as described in the description], or a pharmaceutically acceptable salt thereof.

Abstract: A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

Abstract: A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

Abstract: A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

Abstract: A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

Abstract: A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

Abstract: A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

Abstract: A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.

Abstract: A printing apparatus can quickly cancel a print job without any influence on the other subsequent print jobs when a print cancel instruction is issued. During printing, if a print cancel instruction is inputted from a printer operation unit, a printer function manager notifies a print command interpreter of the cancellation. The print command interpreter searches data processed at that time in a transmission/reception buffer for an end mark command indicating the end of the cancelled job. Then the print command interpreter deletes the data before the end mark command.

Abstract: The present invention provides novel compounds having antiviral activities and antiviral drugs containing the compounds as the active ingredient.

Abstract: Image data is stored on a removable external card together with previous printing information relating to printing of this image data. Accordingly, when printing identical with that executed previously is carried out, the need to make printing settings again is eliminated by performing printing based upon the stored information. By further storing printing paper information in the external card, information regarding a new type of printing paper can be registered in an image processing apparatus with ease. This makes it possible for the apparatus to print properly even on a new type of paper.

Abstract: The present invention provides novel compounds having antiviral activities and antiviral drugs containing the compounds as the active ingredient.

Abstract: Image data is stored on a removable external card together with previous printing information relating to printing of this image data. Accordingly, when printing identical with that executed previously is carried out, the need to make printing settings again is eliminated by performing printing based upon the stored information. By further storing printing paper information in the external card, information regarding a new type of printing paper can be registered in an image processing apparatus with ease. This makes it possible for the apparatus to print properly even on a new type of paper.

Abstract: A printing apparatus which quickly cancels a print job without any influence on the subsequent other print jobs when a print cancel instruction is issued. During printing, if a print cancel instruction is inputted from a printer operation unit 107, a printer function manager 109 notifies a print command interpreter 108 of the cancellation. The print command interpreter 108 searches data processed at that time in a transmission/reception buffer for an end mark command indicating the end of the cancelled job. Then the print command interpreter 108 deletes the data before the end mark command.

Abstract: A novel benzimidazole derivative [specifically, for example, 2-ethoxy-1-[{4′-(2″-N,N-dimethylaminoethoxycarbonyl)phenyl}methyl]-1H-benzimidazole-6-carboxylic acid morpholide] represented by formula (I) and a salt thereof. The compound exhibits satisfactory curative effects for cardiac and nephric diseases, although having little action on blood-pressure.

Abstract: An aromatic compound of the formula (I): ##STR1## specifically, for example, 3-??(4-carboxyphenyl)methyl!valeramido!-4-dimethylaminobenzoic acid 4'-methylpiperazide, or a salt thereof, and a pharmaceutical composition comprising said aromatic compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent which provides sufficiently effective alleviation of renal dysfunction without affecting blood pressure at a low blood concentration.

Abstract: A compound of the formula (I): ##STR1## wherein R.sup.1 and R.sup.2 are, independently, --CON(R.sup.4)R.sup.5, or a monosaccharide, or acylated monosaccharide group, with the proviso that at least one of R.sup.1 and R.sup.2 is --CON(R.sup.4)R.sup.5, and R.sup.4 and R.sup.5 are, independently, a hydrogen atom, or a hydroxyl, alkyl, aryl, or aralkyl group, or R.sup.4 and R.sup.5 together with the nitrogen atom attached thereto form a 3- to 7-membered saturated cycloaliphatic amino group, and R.sup.3 is a hydrogen atom, or a hydroxyl, alkyl, aryl, aralkyl, or --COOR.sup.8 group, and R.sup.3 is at 3- or 4-position, and R.sup.8 is a hydrogen atom or an alkyl group, or a salt thereof is disclosed. The compound has a function to inhibit a matrix metalloproteinase.

Abstract: An image processing apparatus has an image reader, an image memory for storing image data and having an image expanding area for expanding image data, a keyboard for inputting necessary data for editing image data, and a CPU for operating the image data so as to reproduce an image edited in accordance with information input at the keyboard by the operator. Desired areas of an original can be reproduced at desired areas of fan fold paper. When image processing is interrupted during printing, image data already read and stored in a buffer memory can be saved and used for printing when printing is resumed.